4.7 Article

A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy

Related references

Note: Only part of the references are listed.
Editorial Material Multidisciplinary Sciences

HIV Shock and kill

Steven G. Deeks

NATURE (2012)

Review Pharmacology & Pharmacy

Curing HIV: Pharmacologic Approaches to Target HIV-1 Latency

Shailesh K. Choudhary et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)

Review Biochemical Research Methods

Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells

Alberto Bosque et al.

METHODS (2011)

Review Microbiology

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs

Mayte Coiras et al.

NATURE REVIEWS MICROBIOLOGY (2009)

Review Pharmacology & Pharmacy

The status of disulfiram - A half of a century later

Jesse J. Suh et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)

Article Multidisciplinary Sciences

Identification of T cell-signaling pathways that stimulate latent HIV in primary cells

DG Brooks et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemistry & Molecular Biology

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

JD Siliciano et al.

NATURE MEDICINE (2003)